IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $48,297,000 | +150.8% | 567,996 | +4.5% | 0.40% | +82.7% |
Q2 2020 | $19,254,000 | +730.3% | 543,288 | +395.7% | 0.22% | +388.9% |
Q4 2019 | $2,319,000 | +4.7% | 109,597 | -31.4% | 0.04% | -26.2% |
Q2 2019 | $2,215,000 | -8.1% | 159,677 | +37.9% | 0.06% | +15.1% |
Q3 2018 | $2,411,000 | -21.9% | 115,766 | -11.3% | 0.05% | -36.1% |
Q2 2018 | $3,089,000 | -27.4% | 130,495 | -57.1% | 0.08% | -12.6% |
Q3 2017 | $4,252,000 | +556.2% | 304,184 | +314.4% | 0.10% | +493.8% |
Q2 2017 | $648,000 | -50.4% | 73,397 | -63.6% | 0.02% | -50.0% |
Q1 2017 | $1,306,000 | – | 201,870 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |